Transdermal delivery rate control using amorphous pharmaceutical compositions
US8357393B2 · kind B2 · utility
6Cited by
28References
10Claims
0Family size
Assignee
Inventors
Key dates
| Filing date | Dec 7, 2004 |
| Grant date | Jan 22, 2013 |
| Priority date | — |
| Expiry date | Nov 30, 2030 |
Classification
- Technology area (CPC A)Human Necessities
- CPC primaryA61P33/06
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
A pharmaceutical composition for transdermal delivery comprising
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.